Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Hec1 inhibitors(NDC80 kinetochore complex component inhibitors), NEK2 inhibitors(Serine/threonine-protein kinase NEK2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 21 Feb 2024 |